This year, more than 226,000 Americans will die from lung cancer — the number one cancer killer. I live with this knowledge every day because lung cancer has touched my ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Electronic "nose" analysis of exhaled breath achieved 80-90% accuracy for detecting lung cancer in patients with suspicious ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

The US Food and Drug Administration (FDA) has granted clearance to CureVac's investigational new drug application (IND) for ...

The test is presently part of the RISP trial, and the company is on track to commercialise it in the US by 2026.